← Back to the feed

Mabylon AG

History from 20 Jun 2016

UID

CHE-353.226.343

Legal form

AG

Canton

ZH

Founded

not in the record

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 4 Mar 2019 · legal date 26 Feb 2019

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   571’092 → 2’001’630

   Shares

   571’092 → 2’001’630

   New shares, % of post-step shares

   71.5% (1’430’538 new)

   Share classes

   1’108’908 × CHF 1 · 892’722 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 2'001'630.00 [bisher: CHF 571'092.00]. Liberierung Aktienkapital neu: CHF 2'001'630.00 [bisher: CHF 571'092.00]. Aktien neu: 1'108'908 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 100'000 Namenaktien zu CHF 1.00 und 471'092 Namenaktien zu CHF 1.00 (Vorzugsaktien)].

   SHAB HR02-1004578886 ↗

2. SHAB published 16 Jul 2021 · legal date 5 Jul 2021

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   2’001’630 → 2’668’841

   Shares

   2’001’630 → 2’668’841

   New shares, % of post-step shares

   25.0% (667’211 new)

   Share classes

   1’776’119 × CHF 1 · 892’722 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 2'668'841.00 [bisher: CHF 2'001'630.00]. Liberierung Aktienkapital neu: CHF 2'668'841.00 [bisher: CHF 2'001'630.00]. Aktien neu: 1'776'119 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 1'108'908 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien)].

   SHAB HR02-1005250769 ↗

3. SHAB published 26 Jul 2023 · legal date 20 Jul 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   2’668’841 → 3’390’517

   Shares

   2’668’841 → 3’390’517

   New shares, % of post-step shares

   21.3% (721’676 new)

   Share classes

   2’497’795 × CHF 1 · 892’722 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 3'390'517.00 [bisher: CHF 2'668'841.00]. Liberierung Aktienkapital neu: CHF 3'390'517.00 [bisher: CHF 2'668'841.00]. Aktien neu: 2'497'795 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 1'776'119 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien)].

   SHAB HR02-1005804044 ↗

4. SHAB published 28 Sep 2023 · legal date 20 Sep 2023

   Capital band adopted

   SHAB HR02-1005847391 ↗

5. SHAB published 6 Aug 2025 · legal date 28 Jul 2025

   Capital increase

   ●●●Confirmed round

   Paid in cash

   Nominal capital

   3’390’517 → 8’390’517

   Shares

   3’390’517 → 8’390’517

   New shares, % of post-step shares

   59.6% (5’000’000 new)

   Share classes

   7’497’795 × CHF 1 · 892’722 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 8'390'517.00 [bisher: CHF 3'390'517.00]. Liberierung Aktienkapital neu: CHF 8'390'517.00 [bisher: CHF 3'390'517.00]. Aktien neu: 7'497'795 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) und 2'497'795 Namenaktien zu CHF 1.00]. [bisher: Die Gesellschaft hat mit Beschluss vom 20.09.2023 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.].

   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.70 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006401698 ↗

6. SHAB published 6 Aug 2025 · legal date 28 Jul 2025

   Capital band adopted

   SHAB HR02-1006401698 ↗

7. Announced 12 Aug 2025

   Round announced

   matched to a capital increase · high match confidence

   Announcement ↗

8. SHAB published 3 Jul 2026 · legal date 25 Jun 2026

   Capital increase

   ○○○Capital increased

   Paid by converting claims

   Nominal capital

   8’390’517 → 14’272’869

   Shares

   8’390’517 → 14’272’869

   New shares, % of post-step shares

   41.2% (5’882’352 new)

   Share classes

   13’380’147 × CHF 1 · 892’722 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 14'272'869.00 [bisher: CHF 8'390'517.00]. Liberierung Aktienkapital neu: CHF 14'272'869.00 [bisher: CHF 8'390'517.00]. Aktien neu: 13'380'147 Namenaktien zu CHF 1.00 und 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 892'722 Namenaktien zu CHF 1.00 (Vorzugsaktien) und 7'497'795 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 25.06.2026 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5
   • Paid entirely by converting existing claims, with no new money.−1.5

   Classifier score 0.20 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006696250 ↗

9. SHAB published 3 Jul 2026 · legal date 25 Jun 2026

   Capital band adopted

   SHAB HR02-1006696250 ↗

Published by 8 Oct 2026